ATRC
Atricure Inc (ATRC)
Healthcare • NASDAQ • $26.28-5.47%
- Symbol
- ATRC
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $26.28
- Daily Change
- -5.47%
- Market Cap
- $1.33B
- Trailing P/E
- N/A
- Forward P/E
- 75.10
- 52W High
- $43.18
- 52W Low
- $26.08
- Analyst Target
- $47.00
- Dividend Yield
- N/A
- Beta
- 1.28
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cry…
Company websiteResearch ATRC on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.